Healthscope's NZ pathology shares efficiencies with DHBs, stalling earnings growth

Healthscope's NZ pathology shares efficiencies with DHBs, stalling earnings growth
Paul McBeth
By Paul McBeth Aug. 21 (BusinessDesk) - Healthscope's New Zealand pathology business gave up earnings growth as it shared operating efficiencies with district health boards through the re-contracting process.  The New Zealand lab testing division reported a 1 percent decline in revenue to A$240.2 million in the year ended June 30 and a 2.7 percent dip in operating earnings before interest, tax depreciation and amortisation to A$58.1 million. In NZ dollar terms, revenue rose 1.6 percent and earnings 2.5 percent, slowing from the unit's out...